NEW YORK, Feb. 2, 2009 (GLOBE NEWSWIRE) -- Levi & Korsinsky ("L&K") is investigating breaches of fiduciary duty and other violations of state law by the board of directors of NitroMed ("NitroMed" or the "Company") (Nasdaq:NTMD) arising out of their attempt to sell the Company to Deerfield Capital. Under the terms of the agreement, shareholders of NitroMed will receive $0.80 for each share of NitroMed they own for a total transaction value of approximately $36 million. The transaction is unfair, given that, among other things, the Company's shares traded above $1.00 per share as recently as August 2008 and the Company has over $17 million in cash.
If you own common stock in NitroMed and wish to obtain additional information, please contact us at the number listed below or visit http://www.zlk.com/ntmd.html
L&K has experience in prosecuting investor securities litigation and an extensive practice in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.